• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

EU adviser says Illumina merger was not problematic

cafead

Administrator
Staff member
  • cafead   Mar 22, 2024 at 09:42: AM
via Finally, a win for Illumina — for whom it’s been doom and gloom for quite some time, after an $8 billion effort to acquire Grail was blocked by European regulators. Now, Nicholas Emiliou, advocate general of the Court of Justice of the EU, has said that decision was wrong and ought to be reversed, Financial Times writes.

article source
 

<